Contact
Social
Category & trade
Primary
pharmaceutical-drugs · embed-ft 0.29
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Also (top-3)
Tech stack
AI readiness
AI-Readiness score
63 / 100 · ready · see similar
AI training policy
allowed
AI-bot protection
AI files
Evidence
llms.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
Lutris Pharma — Topical B-RAF Inhibitor for Cancer Skin Toxicity
Description
Lutris Pharma develops LUT014, a topical B-RAF inhibitor reducing dermal toxicity of EGFR inhibitors and radiation.
Final URL
Language
en (html)
Scanned at
2026-06-24 10:03:30